EMP16-02

· Empros Pharma AB

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EMP16-02, covering 2022-04-04 to 2022-04-04. Get the full timeline:

Most recent: Clinical Trial Update: A Proof of Concept Trial in Overweight and Obese Patients, Investigating Effect of EMP16-02 on Body Weight (Primary) [Phase 1, Phase 2]

See pricing